Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.
FDA approves Vertex's first-in-class non-opioid analgesic for acute pain
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid analgesic,
US FDA approves Vertex's non-opioid painkiller
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator said on Thursday, offering a first-of-its-kind alternative to addictive opioid painkillers that have fueled a national crisis.
F.D.A. Approves Drug to Treat Pain Without Opioid Effects
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug Administration approved a new medication Thursday to treat pain from an injury or surgery.
2d
China’s influence on Panama Canal poses ‘acute risks to US national security,’ Sen. Cruz warns
China's influence on the Panama Canal is a major risk to U.S. national security, Sen. Ted Cruz told lawmakers during a Senate ...
Managed Healthcare Executive
5d
Acute Stress Disorder vs. PTSD: What’s the Difference?
As with PTSD, people develop acute stress disorder after exposure to traumatic events. The key difference in the diagnostic ...
Impacts
13d
Understanding Acute Stress Disorder: Signs and Symptoms You Should Know
Life is full of unexpected twists and turns, and while many of these can be managed with resilience, some events are so ...
9h
New Study Published in JAMA Network Open Finds Procedural Prescription Denials Can Increase Acute Care Utilization and Spending in Medicaid
A new study published in JAMA Network Open has found that while procedural prescription denials curb immediate drug costs, some denials result in increased acute care utilization and costs, which ...
6h
Activated Insights Announces 2025 Customer Experience Awardâ„¢ Winners, Recognizing Excellence in Long-Term and Post-Acute Care
Activated Insights, the leading provider of training, recruitment, retention, experience management and recognition tools to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback